338 related articles for article (PubMed ID: 34245257)
1. Human Molecular Genetics and the long road to treating cystic fibrosis.
Harris A
Hum Mol Genet; 2021 Oct; 30(R2):R264-R273. PubMed ID: 34245257
[TBL] [Abstract][Full Text] [Related]
2. Genome Editing for Cystic Fibrosis.
Wang G
Cells; 2023 Jun; 12(12):. PubMed ID: 37371025
[TBL] [Abstract][Full Text] [Related]
3. Rewriting CFTR to cure cystic fibrosis.
Maule G; Ensinck M; Bulcaen M; Carlon MS
Prog Mol Biol Transl Sci; 2021; 182():185-224. PubMed ID: 34175042
[TBL] [Abstract][Full Text] [Related]
4. Beyond cystic fibrosis transmembrane conductance regulator therapy: a perspective on gene therapy and small molecule treatment for cystic fibrosis.
Schneider-Futschik EK
Gene Ther; 2019 Sep; 26(9):354-362. PubMed ID: 31300729
[TBL] [Abstract][Full Text] [Related]
5. Gene Therapy for Cystic Fibrosis: Progress and Challenges of Genome Editing.
Maule G; Arosio D; Cereseto A
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486152
[TBL] [Abstract][Full Text] [Related]
6. Advances in gene therapy for cystic fibrosis lung disease.
Yan Z; McCray PB; Engelhardt JF
Hum Mol Genet; 2019 Oct; 28(R1):R88-R94. PubMed ID: 31332440
[TBL] [Abstract][Full Text] [Related]
7. New Therapies to Correct the Cystic Fibrosis Basic Defect.
Bergeron C; Cantin AM
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34201249
[TBL] [Abstract][Full Text] [Related]
8. Applying Cystic Fibrosis Transmembrane Conductance Regulator Genetics and CFTR2 Data to Facilitate Diagnoses.
Sosnay PR; Salinas DB; White TB; Ren CL; Farrell PM; Raraigh KS; Girodon E; Castellani C
J Pediatr; 2017 Feb; 181S():S27-S32.e1. PubMed ID: 28129809
[TBL] [Abstract][Full Text] [Related]
9. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.
Southern KW; Patel S; Sinha IP; Nevitt SJ
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010966. PubMed ID: 30070364
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy in cystic fibrosis.
Prickett M; Jain M
Transl Res; 2013 Apr; 161(4):255-64. PubMed ID: 23273902
[TBL] [Abstract][Full Text] [Related]
11. Transcriptome Profiling and Molecular Therapeutic Advances in Cystic Fibrosis: Recent Insights.
Ideozu JE; Zhang X; McColley S; Levy H
Genes (Basel); 2019 Feb; 10(3):. PubMed ID: 30813620
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Cas9 and Cas12a CRISPR editing methods to correct the W1282X-CFTR mutation.
Santos L; Mention K; Cavusoglu-Doran K; Sanz DJ; Bacalhau M; Lopes-Pacheco M; Harrison PT; Farinha CM
J Cyst Fibros; 2022 Jan; 21(1):181-187. PubMed ID: 34103250
[TBL] [Abstract][Full Text] [Related]
13. A sheep model of cystic fibrosis generated by CRISPR/Cas9 disruption of the CFTR gene.
Fan Z; Perisse IV; Cotton CU; Regouski M; Meng Q; Domb C; Van Wettere AJ; Wang Z; Harris A; White KL; Polejaeva IA
JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282831
[TBL] [Abstract][Full Text] [Related]
14.
Zhou ZP; Yang LL; Cao H; Chen ZR; Zhang Y; Wen XY; Hu J
Hum Gene Ther; 2019 Sep; 30(9):1101-1116. PubMed ID: 31099266
[TBL] [Abstract][Full Text] [Related]
15. One Size Does Not Fit All: The Past, Present and Future of Cystic Fibrosis Causal Therapies.
Ensinck MM; Carlon MS
Cells; 2022 Jun; 11(12):. PubMed ID: 35740997
[TBL] [Abstract][Full Text] [Related]
16. Modifier gene studies to identify new therapeutic targets in cystic fibrosis.
Dorfman R
Curr Pharm Des; 2012; 18(5):674-82. PubMed ID: 22229572
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics of cystic fibrosis treatment.
Carter SC; McKone EF
Pharmacogenomics; 2016 Aug; 17(13):1453-63. PubMed ID: 27490265
[TBL] [Abstract][Full Text] [Related]
18. Cystic fibrosis transmembrane conductance regulator modulators: the end of the beginning.
Barry PJ; Ronan N; Plant BJ
Semin Respir Crit Care Med; 2015 Apr; 36(2):287-98. PubMed ID: 25826594
[TBL] [Abstract][Full Text] [Related]
19. Disease modifying genes in cystic fibrosis: therapeutic option or one-way road?
Büscher R; Grasemann H
Naunyn Schmiedebergs Arch Pharmacol; 2006 Nov; 374(2):65-77. PubMed ID: 17033796
[TBL] [Abstract][Full Text] [Related]
20. Cystic fibrosis: exploiting its genetic basis in the hunt for new therapies.
Kreindler JL
Pharmacol Ther; 2010 Feb; 125(2):219-29. PubMed ID: 19903491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
